Daniel Kroneberg

Dr. Daniel Kroneberg

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019 in Movement Disorders
Verified
Journal Article
Open access
PDF file
USUte Scheller
Ute Scheller
RLRoxanne Lofredi
Roxanne Lofredi
BWBernadette C.M. Van Wijk
Bernadette C.M. Van Wijk
ASAssel Saryyeva
Assel Saryyeva
JKJoachim K. Krauss
Joachim K. Krauss
AKAndrea A. Kühn
Andrea A. Kühn
Objective: This study investigates the association between pallidal low‐frequency activity and motor sign severity in dystonia after chronic deep brain stimulation for several months.Methods: Local field potentials were recorded in 9 dystonia patients at 5 timepoints (T1–T5) during an OFF‐stimulation period of 5 to 7 hours in parallel with clinical assessment using Burke‐Fahn‐Marsden Dystonia Rating Scale. A linear mixed effects model was used to investigate the potential association of motor signs with local field potential activity in the low frequency (3–12 Hz) and beta range (13–30 Hz).Results: A significant association of Burke‐Fahn‐Marsden Dystonia Rating Scale scores with low‐frequency activity (3–12 Hz; b = 4.4; standard error = 1.5, degrees of freedom = 43, P = 0.006, 95% confidence interval, 1.3–7.5), but not beta activity (13–30 Hz) was revealed within participants across timepoints.Conclusion: Low‐frequency activity is associated with dystonic motor sign severity, even months after chronic deep brain stimulation. Our findings corroborate the pathophysiological role of low‐frequency activity in dystonia and highlight the potential utility as a biomarker for adaptive neuromodulation. © 2019 Charité. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson andMovement Disorder Society

1 August 2021 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
DKDorothee Kübler
Dorothee Kübler
DKDaniel Kroneberg
Daniel Kroneberg
BABassam Al-Fatly
Bassam Al-Fatly
GSGerd-Helge Schneider
Gerd-Helge Schneider
SESiobhan Ewert
Siobhan Ewert
AKAndrea A. Kühn
Andrea A. Kühn

14 February 2019 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
DKDaniel Kroneberg
Daniel Kroneberg
SESiobhan Ewert
Siobhan Ewert
AMAnne-Christiane Meyer
Anne-Christiane Meyer
AKAndrea A Kühn
Andrea A Kühn
Objective Gait disturbances are frequent side effects occurring during chronic thalamic deep brain stimulation (DBS) in patients with essential tremor (ET). Adapting stimulation settings to shorter pulse widths has been shown to reduce side effects of subthalamic DBS. Here, we assess how a reduction of pulse width changes gait performance of affected patients. Methods Sensor-based gait assessment was performed to record spatiotemporal gait parameters in 10 healthy subjects (HS) and 7 patients with ET with gait disturbances following thalamic DBS. Patients were tested during standard DBS, after 72 hours of stimulation withdrawal and at least 30 days after adjusting DBS settings to a shorter pulse width of 40 µs (DBS40PW). Results Patients with ET on standard DBS showed significantly higher variability of several spatiotemporal gait parameters compared with HS. Variability of stride length and range of motion of the shanks significantly decreased OFF DBS as compared with standard DBS. This improvement was maintained over 30 days with DBS40PW while providing effective tremor suppression in six out of seven patients. Conclusion Shorter pulse widths may reduce gait disturbances in patients with ET that are induced by DBS while preserving a level of tremor suppression equal to standard stimulation settings.

25 July 2024 in Movement Disorders
Verified
Journal Article
Open access
LGLukas L. Goede
Lukas L. Goede
SOSimon Oxenford
Simon Oxenford
DKDaniel Kroneberg
Daniel Kroneberg
GMGarance M. Meyer
Garance M. Meyer
NRNanditha Rajamani
Nanditha Rajamani
AHAndreas Horn
Andreas Horn
Background: Recent imaging studies identified a brain network associated with clinical improvement following deep brain stimulation (DBS) in Parkinson's disease (PD), the PD response network.Objectives: This study aimed to assess the impact of neuromodulation on PD motor symptoms by targeting this network noninvasively using multifocal transcranial direct current stimulation (tDCS).Methods: In a prospective, randomized, double‐blinded, crossover trial, 21 PD patients (mean age 59.7 years, mean Hoehn & Yahr [H&Y] 2.4) received multifocal tDCS targeting the a‐priori network. Twenty‐minute sessions of tDCS and sham were administered on 2 days in randomized order. Movement Disorder Society‐Unified Parkinson's Disease Rating Scale—Part III (MDS‐UPDRS‐III) scores were assessed.Results: Before intervention, MDS‐UPDRS‐III scores were comparable in both conditions (stimulation days: 37.38 (standard deviation [SD] = 12.50, confidence interval [CI] = 32.04, 42.73) vs. sham days: 36.95 (SD = 13.94, CI = 30.99, 42.91), P = 0.63). Active stimulation resulted in a reduction by 3.6 points (9.7%) to 33.76 (SD = 11.19, CI = 28.98, 38.55) points, whereas no relevant change was observed after sham stimulation (36.43 [SD = 14.15, CI = 30.38, 42.48], average improvement: 0.5 [1.4%]). Repeated‐measures analysis of variance (ANOVA) confirmed significance (main effect of time: F(1,20)=4.35, P < 0.05). Tukey's post hoc tests indicated MDS‐UPDRS‐III improvement after active stimulation (t [20] = 2.9, P = 0.03) but not after sham (t [20] = 0.42, P > 0.05). In a subset of patients that underwent DBS surgery later, their DBS response correlated with tDCS effects (R = 0.55, P(1) = 0.04).Conclusion: Noninvasive, multifocal tDCS targeting a DBS‐derived network significantly improved PD motor symptoms. Despite a small effect size, this study provides proof of principle for the successful noninvasive neuromodulation of an invasively identified network. Future studies should investigate repeated tDCS sessions and their utility for screening before DBS surgery. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

3 February 2024 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
DKDaniel Kroneberg
Daniel Kroneberg
BABassam Al-Fatly
Bassam Al-Fatly
CMCornelia Morkos
Cornelia Morkos
LSLeon Amadeus Steiner
Leon Amadeus Steiner
GSGerd-Helge Schneider
Gerd-Helge Schneider
AKA. Kühn
A. Kühn
Background: Additional stimulation of the substantia nigra (SNr) has been proposed to target axial symptoms and gait impairment in patients with Parkinson’s disease (PD). Objective: This study aimed to characterize effects of combined deep brain stimulation (DBS) of the subthalamic nucleus (STN) and SNr on gait performance in PD and to map stimulation sites within the SNr. Methods: In a double-blinded crossover design, 10 patients with PD and gait impairment underwent clinical examination and kinematic assessment with STN DBS, combined STN+SNr DBS and OFF DBS 30 minutes after reprogramming. To confirm stimulation within the SNr, electrodes, active contacts, and stimulation volumes were modeled in a common space and overlap with atlases of SNr was computed. Results: Overlap of stimulation volumes with dorsolateral SNr was confirmed for all patients. UPDRS III, scoring of freezing during turning and transitioning, stride length, stride velocity, and range of motion of shank, knee, arm, and trunk as well as peak velocities during turning and transitions and turn duration were improved with STN DBS compared to OFF. On cohort level, no further improvement was observed with combined STN+SNr DBS but additive improvement of spatiotemporal gait parameters was observed in individual subjects. Conclusions: Combined high frequency DBS of the STN and dorsolateral SNr did not consistently result in additional short-term kinematic or clinical benefit compared to STN DBS. Stimulation intervals, frequency, and patient selection for target symptoms as well as target region within the SNr need further refinement in future trials.

23 September 2020 in Sensors
Verified
Journal Article
Open access
PDF file
KOKaren Otte
Karen Otte
TETobias Ellermeyer
Tobias Ellermeyer
TVTim-Sebastian Vater
Tim-Sebastian Vater
MVMarlen Voigt
Marlen Voigt
DKDaniel Kroneberg
Daniel Kroneberg
TSTanja Schmitz-Hübsch
Tanja Schmitz-Hübsch
Fluctuations of motor symptoms make clinical assessment in Parkinson’s disease a complex task. New technologies aim to quantify motor symptoms, and their remote application holds potential for a closer monitoring of treatment effects. The focus of this study was to explore the potential of a stepping in place task using RGB-Depth (RGBD) camera technology to assess motor symptoms of people with Parkinson’s disease. In total, 25 persons performed a 40 s stepping in place task in front of a single RGBD camera (Kinect for Xbox One) in up to two different therapeutic states. Eight kinematic parameters were derived from knee movements to describe features of hypokinesia, asymmetry, and arrhythmicity of stepping. To explore their potential clinical utility, these parameters were analyzed for their Spearman’s Rho rank correlation to clinical ratings, and for intraindividual changes between treatment conditions using standard response mean and paired t-test. Test performance not only differed between ON and OFF treatment conditions, but showed moderate correlations to clinical ratings, specifically ratings of postural instability (pull test). Furthermore, the test elicited freezing in some subjects. Results suggest that this single standardized motor task is a promising candidate to assess an array of relevant motor symptoms of Parkinson’s disease. The simple technical test setup would allow future use by patients themselves.